BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8637715)

  • 1. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.
    Soprano DR; Chen LX; Wu S; Donigan AM; Borghaei RC; Soprano KJ
    Oncogene; 1996 Feb; 12(3):577-84. PubMed ID: 8637715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
    Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ
    Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
    Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
    Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
    Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
    Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid.
    Konta T; Xu Q; Furusu A; Nakayama K; Kitamura M
    J Biol Chem; 2001 Apr; 276(16):12697-701. PubMed ID: 11278809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
    van der Leede BM; van den Brink CE; van der Saag PT
    Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
    Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
    Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
    Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
    J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
    Wan YJ; Cai Y; Magee TR
    Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
    Haxsen V; Adam-Stitah S; Ritz E; Wagner J
    Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RXR alpha is essential for mediating the all-trans retinoic acid-induced growth arrest of C2 myogenic cells.
    Froeschlé A; Carnac G; Alric S; Montarras D; Pinset C; Rochette-Egly C; Bonnieu A
    Oncogene; 1996 Jan; 12(2):411-21. PubMed ID: 8570219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
    Lin F; Xiao D; Kolluri SK; Zhang X
    Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of retinoic acid receptors and the effects in vitro by retinoids in human pancreatic cancer cell lines.
    Albrechtsson E; Ohlsson B; Axelson J
    Pancreas; 2002 Jul; 25(1):49-56. PubMed ID: 12131771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
    Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
    Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
    Chen GQ; Lin B; Dawson MI; Zhang XK
    Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid nuclear receptor alpha(RAR alpha) plays a major role in retinoid-mediated inhibition of growth in human breast carcinoma cells.
    Shao Z; Yu L; Shen Z; Fontana JA
    Chin Med Sci J; 1996 Sep; 11(3):142-6. PubMed ID: 9387397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.